DigiPath Explores Cannabis in Midterm Election Politics in New TNMNews Segment

News provided by

Oct 30, 2014, 06:00 ET

LOS ANGELES, Oct. 30, 2014 /PRNewswire/ -- The National Marijuana News, a subsidiary of DigiPath, Inc. (OTCBB andOTCQB: DIGP), has just released its special midterm election edition of its popular, unbiased cannabis news program on www.TNMNews.com.

In this fourth TNMNews segment, hosts Todd Denkin and Jen Gentile discuss the current political and economic climate of the American cannabis industry with Medical Marijuana 411 cofounder Sam Sabzehzar, Marijuana Policy Project (MPP) director Karen O' Keefe, and former international cannabis smuggler and Hemp Inc. founder Bruce Perlowin.

DigiPath, Inc., through its subsidiary, DigiPath, Corp., creates and markets innovative and reliable digital pathology solutions that empower private and academic institutions with the ability to create, store, manage, analyze, and correlate data collected through virtual microscopy. DigiPath, Inc. digital pathology portfolio includes PathScope(TM), PathCloud(TM), PathReview(TM), and PathConsult(TM) digital platforms to share and store archive tissue images. DigiPath, Inc. is expanding into new lines of business associated with the research, development, licensing and operation of botanical and nutrapharmaceutical products and services.

The lineup starts with Sam Sabzehzar, co-founder of the cannabis news website MedicalMarijuana411.com, proclaiming that cannabis is a plant—not a drug—and everyone's body needs 65 mg of phytocannabinoids every day. Because of this, he says, the War on Drugs is a War on People.

Sabzehzar is a filmmaker and political strategist who has traveled the world using art as a platform to help share stories that change people's lives by inspiring them to shift their attitudes and actions in a more positive direction. In the interview, he discusses his alignment with Law Enforcement Against Prohibition, an organization—like Medical Marijuana 411—that believes prohibition is far more dangerous that the thing that it is designed to prohibit.

Next, Karen O' Keefe, attorney and legislative analyst with the MPP, discusses the struggles patients have in areas where legislators have enacted unworkable laws, such as confining grow operations to academic facilities (which will not break federal laws) or requiring a "prescription," although federal law disallows doctors from prescribing cannabis.

O'Keefe gives a rundown on upcoming cannabis ballot measures:

Voters in Alaska will decide on Ballot Measure 2, which would regulate marijuana similarly to the way alcohol is regulated in the state
Oregon's citizens will vote on Measure 91 to allow the recreational use of cannabis in the state
Florida's Right to Medical Marijuana Initiative, Amendment 2, is a constitutional amendment that would need 60 percent of vote to pass

O'Keefe says it has already been a great year for pro-cannabis legislation, pointing to Minnesota becoming the 22nd medical marijuana state last May, Maryland passing two laws reducing the penalties for cannabis possession and allowing the operation of third-party dispensaries, and New York Governor Andrew Cuomo signing a limited medical marijuana bill into law last July.

Founder of Hemp Inc. and counterculture legend Bruce Perlowin, a.k.a. the "King of Pot," wraps up the program with a segment discussing Wall Street's lust for cannabis industry stocks. Perlowin says enthusiasm for investing in cannabis rivals the exuberance experienced during the dot-com era.

Perlowin is a marijuana insider who served nine years in federal prison for smuggling thousands of pounds of marijuana into the United States in the 1970s and 80's. He talks about his previous company, Medical Marijuana Inc., being the first publically traded company in the medical marijuana sector and was also the subject of the highly rated documentary Marijuana Inc. – Inside America's Pot Industry on CNBC.

For more information about TNMNews, please call (800) 549-0859 or go to: www.tnmnews.com.

To book a guest or to advertise on TNMNews, please contact:
Eddie Bernard
[email protected]
(310) 606-0912

About The National Marijuana News
TNMNews examines the medicinal, political, scientific, professional, and social aspects of the controversial cannabis industry, which is legal in 23 states and the District of Columbia. The radio program goes deep and personal, exploring how cannabis has changed lives, and looks to the future with its potential to reshape the economy. TNMNews seeks to report and explore the subject of medical and recreational cannabis from diverse perspectives with an open-minded, fact-based approach.

The news program was soft-launched in June 2014 and has experienced an overwhelmingly positive response, growing its audience from week to week. TNMNews hopes to expand its program to terrestrial radio stations in major US markets while continuing to build a digital audience. TNMNews, Corp. is a wholly-owned subsidiary of DigiPath, Inc.,

About DigiPath, Inc.
DigiPath, Inc., develops and markets accurate and affordable human and animal digital pathology solutions. The company is rapidly expanding into the botanical, nutraceutical, and cannabis industries with industry-leading testing, education, and training services.
For more information, go to www.digipath.com or www.digipath.biz.

Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the in demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. An example of such forward looking statements in this press release includes statements regarding the Company expanding into the botanical, nutraceutical and cannabis industries. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov<http://www.sec.gov/>. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
DigiPath, Inc.
Investor Relations
(888) 552-4440
[email protected]

Logo - http://photos.prnewswire.com/prnh/20140605/94753

SOURCE DigiPath.com